Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy.

Van Aalderen, M C

Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy. [electronic resource] - Journal of thrombosis and haemostasis : JTH Jan 2011 - 223-6 p. digital

Publication Type: Case Reports; Letter

1538-7836

10.1111/j.1538-7836.2010.04133.x doi


Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers--blood
Blood Coagulation--drug effects
Blood Coagulation Tests
Cell-Derived Microparticles--drug effects
Female
Flow Cytometry
Granulocyte Precursor Cells--drug effects
Humans
Leukemia, Myeloid, Acute--blood
Leukocyte Count
Male
Middle Aged
Thrombin--metabolism
Thrombosis--blood
Time Factors
Treatment Outcome
Young Adult